Breastfeeding promotion for management of neonatal abstinence syndrome
Insights
Breastfeeding can reduce neonatal abstinence syndrome (NAS) severity in infants exposed to methadone or buprenorphine during pregnancy. This practice, alongside skin-to-skin contact, aids in managing NAS symptoms and improving infant outcomes.
Area of Science:
- Neonatal care
- Pharmacology
- Public Health
Background:
- Neonatal Abstinence Syndrome (NAS) is a concern for infants exposed to opioids in utero.
- Opioid replacement therapies like methadone and buprenorphine are commonly used during pregnancy.
- The impact of breastfeeding on NAS severity and management requires further understanding.
Purpose of the Study:
- To review literature on the association between breastfeeding and NAS severity.
- To examine the role of breastfeeding in the need for pharmacologic treatment for NAS.
- To assess the effect of breastfeeding on hospital length of stay for neonates exposed to methadone or buprenorphine.
Main Methods:
- Literature search of PubMed, CINAHL, and Medline (1990-2013).
- Keywords included opioid dependency, NAS, methadone, buprenorphine, breastfeeding, and related terms.
- Inclusion criteria focused on English-language studies concerning breastfeeding for NAS management.
Main Results:
- Breastfeeding effectively decreases NAS symptoms due to methadone and buprenorphine transfer via breast milk.
- Maternal contact during breastfeeding plays a significant role in ameliorating NAS symptoms.
- Supportive interventions like skin-to-skin contact, swaddling, and rooming-in enhance breastfeeding benefits for NAS.
Conclusions:
- Clinicians should understand the benefits of breastfeeding for opioid-dependent mothers and neonates.
- Breastfeeding can be safely recommended to improve the long-term health of high-risk infants.
- This review assists clinicians in supporting opioid-dependent women to successfully breastfeed their infants.
Objective:
To review the literature about the association between breastfeeding and neonatal abstinence syndrome (NAS) severity, need for pharmacologic treatment for NAS, and length of hospital stays in neonates with in-utero exposure to methadone or buprenorphine opioid replacement therapy.
Data Sources:
PubMed, CINAHL, and Medline were searched for articles published between January 1990 and April 2013 using the terms opioid dependency in pregnancy, neonatal abstinence syndrome, methadone, buprenorphine, neonatal length of stay, breastfeeding, methadone in breast milk, buprenorphine in breast milk, swaddling, and rooming-in.
Study Selection:
Inclusion criteria included studies written in English on the topic of breastfeeding for management of NAS.
Data Extraction:
The author independently reviewed each article.
Data Synthesis:
Breastfeeding can effectively decrease NAS symptoms because methadone and buprenorphine are transferred to the breast milk. Maternal contact while breastfeeding also plays a role in ameliorating the NAS symptoms. Interventions that also support breastfeeding in the treatment of NAS include skin-to-skin contact, swaddling, and rooming-in.
Conclusions:
Understanding the benefits of breastfeeding for opioid-dependent pregnant women and their neonates will enable clinicians to safely recommend breastfeeding for long-term health of these high-risk women and their infants. This review of the effects of in-utero exposure to opioids on infant development can assist clinicians to more effectively support opioid-dependent women to breastfeed their infants.
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Development of the Oral Microbiota
Parental Care
Pharmacokinetics in Pediatric Patients: Drug Excretion
Development of Human Microbiota
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...


